Unproven Stem Cell Claims and Travel: Questions to Ask Before You Go

By the Regenerative Evidence Guide Team

Evaluating an Unproven Stem Cell Claim Before You Travel

Evaluating an unproven stem cell claim before you travel means asking the same evidence, safety, and cost questions you’d ask at a clinic down the street — a discounted travel package or a plane ticket doesn’t change what counts as proof, and distance can make problems harder to fix if something goes wrong.

Say a family member has knee pain that hasn’t improved with physical therapy. A clinic’s website — maybe overseas, maybe a few states away — promises a stem cell procedure that “regenerates” the joint, bundled with a hotel, at a rate that expires in a week. This guide walks through what to check before booking, organized as stages: understanding the claim, checking the evidence, planning for safety, and deciding whether to go.

Read This First: Warning Signs That Should Stop the Trip

The U.S. Food and Drug Administration (FDA) has received reports of blindness, tumor formation, infections, and other serious harm linked to unapproved products marketed as regenerative medicine therapies, including cells recovered from a person’s own body. Before anything else, know these red flags identified by the International Society for Stem Cell Research (ISSCR), a nonprofit scientific society that publishes patient guidance on stem cell treatments:

• Testimonials instead of published, peer-reviewed research back the claim.
• One treatment is offered for very different conditions — joint pain, heart disease, and neurological conditions alike.
• The cell source or procedure isn’t clearly documented in writing.
• “No risk” is promised. Every procedure that introduces cells into the body carries risk.
• Cell “banking” is upsold for vague future use against unrelated diseases.
• “No approval needed” is the answer when you ask about regulatory oversight.
• Total cost, including emergencies, is unclear.

If a clinic’s marketing matches several of these patterns, that’s reason enough to slow down before booking anything.

Stage One: What Is Actually Being Offered?

Stem cell treatments generally fall into three categories, and the difference matters for safety:

• Approved treatments have gone through formal clinical trials and been cleared by a regulator such as the FDA. Right now, the clearest example is blood (hematopoietic) stem cell transplantation, used for certain blood cancers and immune conditions.
• Investigational treatments are being tested in registered, regulator-overseen clinical trials, but haven’t been proven effective or safe yet.
• Unproven “treatments” haven’t gone through a regulated trial process at all. The FDA describes these as broadly marketed products — including stem cells, fat-derived cells, umbilical cord blood, amniotic fluid, and exosomes — offered for conditions ranging from arthritis to neurological disease without trial evidence to back the claims.

Ask the clinic directly, in writing: Which of these three categories does this procedure fall into, and how do you know? A clinic that can’t answer clearly, or dismisses the question, has told you something important.

One overseas-specific wrinkle: being listed on ClinicalTrials.gov, or a clinic saying it’s “FDA registered,” does not mean a product is approved or legally marketed. The FDA has stated directly that registration and trial-database listings are sometimes used to imply compliance that doesn’t exist.

Stage Two: Questions the Evidence Should Answer

ISSCR’s patient guidance recommends getting written answers to these before a trip is booked. They apply the same way whether the clinic is abroad or nearby:

• What published, peer-reviewed evidence supports this treatment for this specific condition? Has the clinic run any trials on it itself, and what were the results?
• Is there independent oversight of the treatment plan — an ethics board or institutional review board? Can the clinic name independent scientists or clinicians who can speak to it?
• Has this specific use been approved or cleared by a national regulator for this specific condition?
• What is the source of the cells, and how are they processed?

A signed Informed Consent or Treatment Consent Form should be part of this conversation. ISSCR notes this document should be in plain language, describe the treatment honestly, name the risks, explain what happens if something goes wrong, and be given to you as a copy.

Stage Three: What Travel Adds to the Risk Picture

Distance changes what happens if something goes wrong, which is why these questions belong on the checklist specifically because a trip is involved:

• Emergency care. If a complication happens at the clinic, who provides emergency treatment, and is the facility equipped to handle something serious, such as a severe allergic reaction?
• Insurance coverage. Before traveling, find out — in writing — what your health insurance, travel insurance, or national health program will and won’t cover, in which countries, and under what circumstances. Coverage for complications from an unproven procedure abroad is often limited or excluded.
• Getting home with a complication. If a problem develops after you’ve returned home, will the clinic still be reachable, and who provides follow-up care, and for how long? A local doctor may be treating a complication from a procedure they weren’t involved in and don’t have full records for.
• Cost if something goes wrong. Ask specifically who pays for additional treatment, extended hospital stays, or emergency transport — before you travel, not after.

Stage Four: The Cost Conversation

It is not standard practice to pay a fee to participate in a legitimate clinical trial. ISSCR notes that charging participants a fee to take part in a trial is itself considered a warning sign of a problematic study. If a “clinical trial” comes with a package price, that’s worth questioning directly.

For any paid procedure — trial or not — ask what the total price includes, what isn’t included, and whether costs tied to complications, follow-up visits, or emergency care sit outside the advertised package.

A Simple Decision Path

1. Get it in writing. Ask the clinic to answer the evidence, safety, and cost questions above in writing before you book travel.
2. Check independently. Look for the clinic’s claims in published, peer-reviewed research — not just on the clinic’s own site — and check whether the specific procedure has regulatory approval for your condition.
3. Get a second opinion. ISSCR’s guidance recommends discussing the offer with an independent physician who has no financial connection to the clinic, before deciding.
4. Confirm coverage. Contact your insurer directly about what’s covered abroad and under what circumstances, before travel is booked.
5. Decide with the full picture — evidence, oversight, safety plan, and true cost — rather than a travel deadline or discounted package price.

If any step turns up a gap the clinic can’t or won’t close, that gap doesn’t get smaller because a flight is already booked.

If You’ve Already Had a Procedure

If you experience a side effect or complication after receiving a stem cell product, the FDA encourages reporting it through the MedWatch Adverse Event Reporting program, and you can also contact FDA’s Office of Combination Products directly to report a concern. If you’re experiencing a medical emergency, contact local emergency services right away rather than waiting to reach the clinic.

Common Questions

Does it matter if the clinic is in another country?

The evidence and safety questions don’t change, but the practical risks do. A clinic abroad may fall under different regulatory oversight, and getting emergency or follow-up care once you’re home is harder to arrange from a distance.

Is being listed on ClinicalTrials.gov proof that a treatment is approved?

No. The FDA has stated that inclusion in a clinical trial database, or a firm’s registration with FDA, does not mean a product is legally marketed or approved for use.

Is it normal to be charged a fee to take part in a clinical trial?

No. ISSCR notes it is not customary to pay to participate in a legitimate clinical trial, and that charging a fee is itself a warning sign worth investigating further.

What should I do if something goes wrong after a procedure?

For a medical emergency, contact local emergency services immediately. To report a side effect or adverse event afterward, the FDA’s MedWatch program is the designated reporting channel.

Where This Guide Stops

This article explains what questions to ask and what the recognized warning signs are — it does not identify which clinics or procedures are safe, evaluate any specific offer, or recommend for or against any treatment. Only a qualified, independent physician who knows your medical history can weigh in on your specific situation. For a broader look at how stem cell research and evidence quality are evaluated in general, see How We Research. If you’re new to evaluating regenerative medicine claims, Start Here is a good starting point.

This article is for general educational purposes and is not medical advice. It does not diagnose, treat, or recommend for or against any procedure, clinic, or provider. Speak with a qualified, independent healthcare provider about your specific situation, and contact local emergency services for any medical emergency. Regenerative Evidence Guide is an independent editorial publication and is not affiliated with any clinic, treatment provider, or the site’s former organization.

By Regenerative Evidence Guide Editorial Team. Last updated September 11, 2026.